생명 과학 시장 조사의 제조 실행 시스템 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00029831
  • Category : Technology, Media and Telecommunications
  • Status : Published
  • No. of Pages : 214
Buy Now

생명과학 시장의 제조 실행 시스템은 2022년 31억 3914만 달러에서 2033년까지 104억 5654만 달러에 이를 것으로 예상됩니다. 2023년부터 2033년까지 연평균 성장률(CAGR) 12.0%로 성장할 것으로 예상됩니다.

제조 실행 시스템(MES)은 상품 프로세스를 추적, 모니터링, 문서화 및 제어하는 데 도움이 되는 포괄적이고 역동적인 솔루션입니다. 제조, 원자재부터 완제품까지. 또한 이러한 솔루션은 의사결정자에게 생산 현장 운영을 최적화하고 생산 효율성을 향상시키는 데 활용할 수 있는 다변량 데이터를 제공합니다. 또한 제약 제조 공장에 MES를 구현하면 제조업체는 일정 및 리소스 활용도를 개선하고, 제조 유연성 및 프로세스 전환을 향상하고, 진행 중인 작업(WIP)을 줄이고, 자재 추적을 개선하고, 생산 주기를 단축하고, 생산 기록 오류를 낮추고, 제품 리콜을 최소화할 수 있습니다. .

생명과학 시장의 제조 실행 시스템 - 전략적 통찰

Pharma 4.0 채택 증가로 생명과학 시장 성장 촉진

The 제약 산업의 디지털화 증가로 인해 생명 과학 시장 규모에서 제조 실행 시스템이 성장하는 데 기여하는 요인 중 Pharma 4.0에 대한 수요가 증가하고 있습니다. 이 모델은 연결성과 생산성을 높이고 규정 준수를 단순화하며 생산 정보를 정리하여 문제가 발생할 때 이에 대응하도록 돕습니다. Pharma 4.0 모델은 작업자를 보다 인간 중심적인 워크플로에 연결하여 제조 프로세스를 혁신하는 데 도움이 됩니다. ISPE(국제제약공학학회)와 회원들은 Pharma 4.0을 도입하기 위한 로드맵을 개발하고 있습니다. Pharma 4.0 모델의 목표는 조직이 디지털화의 잠재력을 최대한 활용하여 더 빠른 치료 혁신을 제공하고 환자를 위한 생산 프로세스를 개선할 수 있도록 하는 것입니다.

Pharma 4.0 생태계의 주요 업체들은 동일한 도입을 가속화하기 위해 협력하고 있습니다. 예를 들어, 2021년 3월 Lonza와 NNIT는 MES 프로젝트 속도를 높이기 위한 파트너십을 발표했습니다. 이번 파트너십에 따라 양사는 Lonza의 MODA 플랫폼과 NNIT의 Accelerated Implement Methodology를 결합하게 됩니다. 이를 통해 기업은 완전한 Pharma 4.0 솔루션을 확보하고 그 어느 때보다 빠르게 디지털화 비전을 달성할 수 있습니다. 따라서 Pharma 4.0의 채택 증가는 생명 과학 시장 성장에서 제조 실행 시스템을 촉진합니다.

생명 과학 시장에서 제조 실행 시스템의 수익성이 높은 지역

< p>

시장 통찰력 – 생명 과학 시장의 제조 실행 시스템

지역을 기준으로 시장 제조 실행 시스템 시장은 북미, 유럽, 아시아 태평양, 남미, 중동 및 지역으로 분류됩니다. 아프리카. 북미는 2022년 생명과학 시장 점유율에서 제조 실행 시스템을 장악했습니다. 이 지역의 시장은 미국, 캐나다 및 멕시코로 더욱 세분화됩니다. 북미는 발전된 지역 중 하나입니다. 이 지역의 제약, 생명공학 및 기타 여러 산업은 고도로 발전된 기술과 자동화된 운영을 채택하는 것으로 알려져 있습니다. 제약, 의료기기 제조, 생명공학 기업은 생산 단위의 생산성과 관리를 개선하기 위해 MES를 구현하고 있습니다. Abbot, Baxter International, Genitope Corporation, Merck & Co. 따라서 디지털 혁신의 채택이 늘어나면서 향후 북미 생명과학 시장 규모에서 제조 실행 시스템이 강화될 것으로 예상됩니다.

배포 기반 통찰력

생명 과학 시장의 제조 실행 시스템은 배포에 따라 클라우드와 온프레미스로 구분됩니다. 온프레미스 부문은 2022년 생명과학 시장 점유율에서 더 큰 제조 실행 시스템을 보유했지만, 클라우드 부문은 예측 기간 동안 더 높은 CAGR을 기록할 것으로 예상됩니다. 클라우드 부문은 확장성 및 비용 효율성과 같은 몇 가지 유리한 특성으로 인해 크게 성장하고 있습니다. 클라우드 네이티브 MES는 인터넷을 통해 실행되는 SaaS(Software-as-a-Service) 솔루션 형태로 제공됩니다. 이러한 MES 솔루션을 사용하면 관련된 모든 직원이 언제든지 수행할 수 있는 실시간 작업에 액세스할 수 있습니다. Pharma 4.0의 채택이 증가함에 따라 제약 회사는 클라우드 기반 솔루션으로 빠르게 전환하고 있습니다. 주요 MES 제공업체도 이러한 변화를 촉진하고 지원하기 위한 조치를 취하고 있습니다. 2023년 2월 General Electric은 'Proficy Smart Factory 포트폴리오'에 클라우드 기반 MES 소프트웨어를 통합한다고 발표했습니다.

생명과학 시장의 제조 실행 시스템은 제공, 배포, 조직을 기준으로 분류됩니다. 크기 및 응용 프로그램. 생명과학 시장의 제조 실행 시스템은 제품에 따라 소프트웨어와 서비스로 구분됩니다. 배포 측면에서 생명과학 시장의 제조 실행 시스템은 온프레미스와 클라우드로 구분됩니다. 조직 규모에 따라 생명과학 시장의 제조 실행 시스템은 중소기업과 대기업으로 구분됩니다. 응용 분야에 따라 생명 과학 시장의 제조 실행 시스템은 제약, 생명 공학 및 의료 기기로 분류됩니다. 지리를 기준으로 생명 과학 시장의 제조 실행 시스템은 주로 북미, 유럽, 아시아 태평양(APAC), 중동 및 지역으로 분류됩니다. 아프리카(MEA) 및 남아메리카(SAM).

Korber AG, Siemens AG, General Electric, Emerson Electric, Schneider, Rockwell Automation, Apprentice FS Inc, ATS Global, Atachi Systems, LZ Lifescience Ltd, POMS Corporation과 Schneider Electric은 생명 과학 시장의 제조 실행 시스템 분야의 주요 업체 중 하나입니다.

생명 과학 시장의 제조 실행 시스템 업체는 주로 고객 가치 창출을 위한 파트너십에 중점을 둡니다.

< ul>
  • 2022년 5월 제조 실행(MES), 품질 관리 시스템(QMS) 및 공장 자동화 솔루션 제공업체인 Eyelit은 영국 기반 제조 서비스형 소프트웨어(SaaS)인 MESTEC 인수를 발표했습니다. 공급업체. 두 고객 중심 솔루션 제공업체의 파트너십을 통해 Eyelit은 다양한 업계에 제조 소프트웨어 솔루션을 제공할 수 있게 되었습니다.
  • 2022년 9월 Siemens Digital Industries Software는 새로운 OEM(주문자 상표 부착 생산) 파트너십을 체결했습니다. 사이보드와 함께.
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What is the estimated global market size for manufacturing execution system in life sciences market?

    The global manufacturing execution system in life sciences market was estimated to be US$ 3,139.14 million in 2022 and is expected to grow at a CAGR of 12.0%, during the forecast period 2023 - 2033.

    What are the driving factors impacting the global manufacturing execution system in life sciences market?

    Manufacturing execution system in life sciences market is being driven by the need for compliance with regulatory framework and requirement of accurate real-time data in production management process. Additionally, rising application in cell and gene therapy sector are expected to provide growth opportunities for the manufacturing execution system in life sciences market.

    What are the future trends for manufacturing execution system in life sciences market?

    Increasing shift from legacy to modern MES are expected to play a crucial role in the future of the manufacturing execution system in life sciences market. It helps enhance pharmaceutical industry production processes without requiring custom coding. Additionally, the fast and flexible responsiveness of the modern MES solution will make it easier to change production lines and accommodate small batches.

    Which are the key players holding the major market share of manufacturing execution system in life sciences market?

    The key players, holding majority shares, in manufacturing execution system in life sciences market includes Korber AG, Siemens AG, Emerson Electric, Rockwell Automation, and Dassault Systemes.

    Which is the fastest growing regional market?

    Asia Pacific is the fastest growing regional market, followed by Europe.

    Which countries are registering a high growth rate during the forecast period?

    India, China, and Germany are expected to register high growth rates during the forecast period.

    Which is the leading offering segment in the manufacturing execution system in life sciences market?

    The services segment led the manufacturing execution system in life sciences market with a significant share in 2022 and expected to be fastest growing.

    What will be the global market size for manufacturing execution system in life sciences market by 2033?

    The manufacturing execution system in life sciences market is expected to reach US$ 10,456.54 million by 2033.

    What is the incremental growth of the manufacturing execution system in life sciences market during the forecast period?

    The incremental growth, expected to be recorded for the manufacturing execution system in life sciences market during the forecast period, is US$ 7,083.22 million.

    The List of Companies - Manufacturing Execution System in Life Sciences Market 

    1. Korber AG
    2. Siemens AG
    3. Emerson Electric
    4. Schneider Electric
    5. Rockwell Automation
    6. Apprentice FS Inc
    7. ATS Global
    8. Atachi Systems
    9. LZ Lifescience Ltd
    10. POMS Corporation

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports